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ABSTRACT: The number of publications in the field of chemical cross-linking combined with mass spectrometry (XL-MS) to derive con-
straints for protein three-dimensional structure modeling and to probe protein-protein interactions has increased during the last years. As the 
technique is now becoming routine for in vitro and in vivo applications in proteomics and structural biology there is a pressing need to define 
protocols as well as data analysis and reporting formats. Such consensus formats should become accepted in the field and be shown to lead to 
reproducible results. This first, community-based harmonization study on XL-MS is based on the results of 32 groups participating world-
wide. The aim of this paper is to summarize the status quo of XL-MS and to compare and evaluate existing cross-linking strategies. Our study 
therefore builds the framework for establishing best practice guidelines for conducting cross-linking experiments, performing data analysis, 
and reporting formats with the ultimate goal of assisting scientists to generate accurate and reproducible XL-MS results. 
INTRODUCTION. Mass spectrometry (MS) is becoming in-
creasingly popular in the field of structural biology, with great 
implications for solving important biological questions. A central 
technique in structural MS is chemical cross-linking combined with 
 MS (XL-MS). Since 2000, XL-MS and computational modeling 
has advanced from investigating three-dimensional structures of 
isolated proteins to deciphering protein interaction networks1-4. In 
the field of integrated structure analysis, XL-MS is often used in 
conjunction with cryo-electron microscopy. As the chemical XL-
MS approach allows the capture of transient and weak interactions, 
it is now becoming a routine technique for unraveling protein 
interaction networks in their natural cellular environment5. The 
knowledge obtained will significantly advance our understanding of 
the structure of functional complexes, the topology of cellular 
networks and molecular details underlying human pathologies. 
Briefly, the XL-MS approach relies on adding a chemical reagent to 
a protein solution connecting two functional groups of amino acid 
side chains. Cross-linker molecules consist of two reactive groups 
that are separated via a spacer of defined length that allow to derive 
distance information of a protein or a protein assembly. The cross-
linked residues are usually identified after enzymatic digestion of 
the covalently connected protein(s) using LC/ESI-MS/MS (liquid 
chromatography electrospray ionization tandem mass spectrome-
try) and the resulting fragment ion spectra are computationally 
assigned to the cross-linked peptides. The distance constraints 
imposed by the chemical cross-linker on the protein’s tertiary 
structure serve as a basis for subsequent computational modeling 
studies to derive three-dimensional structural models (Scheme S1). 
XL-MS can be applied to both proteins and protein complexes and 
in the case of protein assemblies, the distance constraints can be 
used to map the subunit topology. XL-MS is now increasingly 
being used for deriving protein-protein interaction maps, both in 
vitro and in vivo, where interacting proteins are covalently con-
nected by the cross-linking reaction.6-13 
The wide acceptance of XL-MS by the proteomics and structural 
biology communities reflects the increasing importance of cross-
linking data for elucidating protein structures and protein-protein 
interactions. However, the growth of the user base brings about 
challenges of its own: Even a relatively superficial glance at the 
literature shows a huge diversity of cross-linkers, experimental 
workflows, and computational pipelines. Moreover, the infor-
mation provided in scientific research articles that contain cross-
linking data can range from being quite detailed to very brief.  
The heterogeneity of cross-linking protocols has mainly emerged 
from the use of different cross-linking chemistries and different 
designs of the corresponding cross-linker (e.g., non-
cleavable/cleavable, isotope-coded, or affinity-tagged reagents). 
This, in turn, necessitated individual software solutions specifically 
tailored to the analysis of data from the experimental workflow. 
The most common database search engines used in proteomics are 
not directly suitable for interpreting mass spectra from cross-linked 
peptides. Therefore, the majority of computational solutions have 
emerged from laboratories that pioneered the application of XL-
MS and created tools specifically tailored for the analysis of cross-
linked peptides. Together with a current lack of formal or even 
informal reporting standards, the present state of XL-MS may 
confuse researchers that are interested in interpreting results from 
XL-MS studies or in adopting the technology. Currently, it is not 
clear, which strategies are most suitable in general or for a particular 
application, which makes it challenging to objectively compare 
results obtained by different groups. 
Certainly, the challenges summarized above resemble those of 
other disciplines. In particular, scientists active in “conventional” 
proteomics research have tried to address the very same issues over 
the last decade. Inter-laboratory and software comparison studies 
have been performed for different experimental strategies, includ-
ing data-dependent acquisition14, selected reaction monitoring15-18, 
and most recently, data-independent acquisition19,20. In addition, 
regular comparative studies have been organized by the Association 
of Biomolecular Resource Facilities (ABRF; 
https://abrf.org/research-group/proteomics-research-group-prg 
and https://abrf.org/research-group/proteomics-standards-
research-group-sprg). Together, these studies revealed limitations 
in commonly used experimental and computational workflows, but 
on the other hand also provided evidence for the robustness of a 
particular technique when implemented in different laboratories 
according to standard operating procedures. 
Standardized file formats and reporting guidelines for proteomics 
have been developed under the auspices of the Proteomics Stand-
ards Initiative (PSI) of the Human Proteome Organization 
(http://www.psidev.info)21. For example, as far back as 2007, the 
first recommendations for minimum reporting standards in prote-
omics (Minimum Information About a Proteomics Experiment, 
MIAPE) have been made22, which have been followed by detailed 
guidelines of several proteomics journals. PSI has also formalized 
open-file formats, such as the mzML format for raw MS data23 and 
the mzIdentML format for protein identifications24. Such guide-
lines and open data formats have also led to an increase in the 
deposition of proteomics data in open data repositories such as the 
PRoteomics IDEntifications (PRIDE) archive, hosted by the Euro-
pean Bioinformatics Institute 
(https://www.ebi.ac.uk/pride/archive/)25, via the Proteo-
meXchange initiative (https://www.proteomexchange.org)26. 
Initiatives for establishing standards and recommendations of best 
practices within structural MS techniques, ion mobility-MS 
(https://chemrxiv.org/articles/Recommendations_for_Reporting
_Ion_Mobility_Mass_Spectrometry_Measurements/7072070), 
hydrogen/deuterium exchange (manuscripts in preparation), and 
native MS are or have recently emerged. Likewise, there is also a 
clear need for the objective assessment of the methods and report-
ing standards within the field of XL-MS. For this purpose, several 
researchers active in the field of XL-MS decided to start a commu-
nity-organized effort with the goal of providing a first overview of 
common procedures in XL-MS to generate the basis for best prac-
tices in the field.  
In this first inter-laboratory effort, 32 groups worldwide contribut-
ed, delivering a total of 58 cross-linking data sets. The data reflect 
the great diversity of experimental and computational strategies 
employed and to our knowledge, this is the first comprehensive 
study with the aim to harmonize the XL-MS field. 
 
RESULTS.  
 
Study Design. We opted for a simple study design to encourage 
participation from as many laboratories as possible, including those 
with currently only little experience in XL-MS. Invitations were 
sent out to research groups known to be active in the field from 
their published work and to attendants of the Symposium of Struc-
tural Proteomics (SSP, http://www.structuralproteomics.net/) 
 meeting series. The guidelines were kept quite simple and each 
participant was provided with a template spreadsheet to document 
their method and report their results (Supporting Information). 
Bovine serum albumin (BSA), a protein with a molecular weight of 
~66 kDa, was selected as study system. We requested that a certain 
product from a widely available supplier should be used, and it was 
specified to use a BSA concentration of 10 μM. Apart from these 
restrictions, we left the contributing labs full freedom to choose the 
experimental and computational strategies of their choice. This 
included, among other parameters, flexibility regarding the choice 
of cross-linking reagent and its concentration, buffer composition 
and pH, reaction time and temperature, post-cross-linking sample 
processing (digestion protocol, optional fractionation and enrich-
ment of cross-linked products), conditions for LC/MS analysis, 
and data analysis procedures (choice of software, search parame-
ters, validation of the results). In short, we expected that partici-
pants would use the typical XL-MS workflows established in their 
labs. The protocols used by the individual participating labs were 
collected and analyzed in the Sinz lab and are summarized in the 
Supporting Information. 
For data analysis, we provided the amino acid sequence of mature 
BSA after cleavage of the signal peptide and propeptide sequences 
(residues 25-607 of the UniProt entry P02769; 
https://www.uniprot.org/uniprot/P02769) to ensure a uniform 
numbering scheme. Finally, we encouraged participants to perform 
at least three replicates. As mentioned above, we provided a tem-
plate spreadsheet (Supporting Information) that needed to be 
completed by the participants before a data set would be consid-
ered for inclusion in the detailed assessment of the results. An 
overview of the data sets provided by different labs is presented in 
Figure 1. 
  
 
Figure 1. Overview of data sets provided by the participants of this 
study. 32 groups participated in this study, yielding 58 separate cross-
linking workflows. Nine datasets had to be excluded due to missing 
replicates and non-uniform conditions, resulting in a total of 49 da-
tasets that were further considered. Several workflows contain both in-
solution (47 samples) as well as in-gel digestion (10 samples) as pro-
cessing methods. The samples were considered only once during a 
workflow analysis. 
Protein System. BSA was selected as model protein for this study as 
it is a globular and stable protein that is readily available at low cost. 
Moreover, the three-dimensional structure of BSA is well-known 
and we selected the Protein Data Bank entry 4F5S 
(https://www.rcsb.org/structure/4F5S) for further interpretation 
of the results. As BSA possesses a tendency towards forming di-
mers, this has to be considered when interpreting the results (see 
also below).  
 
Cross-linking Reagents. As outlined above, the participants of this 
study were free to choose the cross-linking principle(s) on their 
own (Table S1; Supporting Information). The majority of groups 
decided to use non-cleavable, homobifunctional, amine-reactive N-
hydroxysuccinimide (NHS) cross-linkers, i.e., 
bis(sulfosuccinimidyl)suberate (BS3) or disuccinimidylsuberate 
(DSS) (Figure 2a). Both cross-linkers only differ by a sulfonic acid 
group that is incorporated for increased water solubility and bridge 
a distance of 11.4 Å, resulting in Cα-Cα distances of ~27 Å to be 
cross-linked27. MS-cleavable cross-linkers, such as disuccinimidyl-
sulfoxide (DSSO) and disuccinimidyldibutyric urea (DSBU), are 
increasingly being used as they allow a targeted identification of 
cross-linked product based on characteristic reporter ions generat-
ed during MS/MS experiments. MS-cleavability as a cross-linker 
feature is essential to reduce the search space in conducting prote-
ome-wide cross-linking studies. The vast majority of cross-linkers 
used herein target amine groups in proteins, i.e., lysine side chains, 
while carboxylic acid groups, such as aspartic and glutamic acid 
residues, are less frequently targeted (Figure 2b). The main spacer 
lengths of the cross-linkers are determined by the three most abun-
dant cross-linkers used in this study are: BS3 and DSS (both 11.4 
Å), DSBU (12.5 Å), and DSSO (10.1 Å) (Figure 2c). 
 
 
Figure 2. (a) Cross-linking reagents used in this study; non-cleavable 
cross-linkers are presented in red, MS-cleavable cross-linkers are 
shown in blue; (b) reactivity, (c) spacer length. The cross-linkers used 
in this study are: BS3 (bis(sulfosuccinimidyl)suberate, DSS (disuccin-
imidylsuberate), DSP (dithiobis(succinimidylpropionate)), DMTMM 
(4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chlo-
ride) with and without PDH (pimelic acid dihydrazide), sulfo-SDA 
(sulfosuccinimidyl 4,4'-azipentanoate), CBSS (carboxybenzophenone 
sulfosuccinimide), DSSO (disuccinimidylsulfoxide), DSBU (disuccin-
imidyldibutyric urea), BDP-NHP (N-hydroxyphthalamide ester of 
biotin aspartate proline), CBDPS (cyanurbiotindimercaptopropionyl 
succinimide), DC4 (1,4-bis(4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-
oxobutyl)-1,4-diazabicyclo[2.2.2]octane-1,4-diium), and MC4 (N,N’-
bis(4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-oxobutyl)-morpholine).  
Reaction Conditions. The reaction conditions were also kept com-
pletely open to the participants, including cross-linking reaction 
time, temperature, cross-linker excess, and pH value of the cross-
linking solution (Figure 3). Not surprisingly, the pH value of the 
 cross-linking reaction mixture was kept around pH 7.4 to 7.5 in the 
majority of experiments in order to resemble the physiological pH 
situation. A pH value of 8.0 that was also used in some experiments 
has the advantage of enhancing the reactivity of NHS esters with 
nucleophiles. The temperature was kept to 20, 25 or 37 °C in the 
majority of experiments, with lower temperature being applied only 
by a few groups. For BSA, a temperature of 37 °C certainly does not 
present a problem as it is a stable, globular protein, but for delicate 
and unstable proteins one should take care to conduct the cross-
linking reaction at lower temperatures. 
 
Instrument Platforms and Settings Used to Generate XL-MS Data. 
The overwhelming majority of cross-linking data were generated 
on Orbitrap mass spectrometers (Figure 4). Only two FTICR 
(SolariX and Velos FTICR) mass spectrometers and one Q-TOF 
(Synapt G2 SI) instrument were employed (Figure 4a). All groups 
used LC/ESI-MS/MS analysis, applying for most experiments a 
resolving power of 60,000 or 120,000 (at m/z 200 or 400, as speci-
fied by the manufacturer Thermo Fisher Scientific for orbitrap 
instruments) (Figure 4b). For MS/MS experiments, a resolving 
power of 15,000 or 30,000 was employed in most cases (Figure 4c). 
Details on enrichment of cross-linked species, considered charge 
states, fragmentation methods, and MS3 resolution are presented 
in the Supporting Information (Figure S1). 
 
 
Figure 3. (a) Time, temperature, and cross-linker excess (XL-fold) 
were set as variable parameters, presented as grey spheres. The colored 
dots are projections of the 3D space onto 2D planes. (b) The pH 
values of the cross-linking reactions ranged between 7.0 to 8.2. 
 
Figure 4. LC/MS/MS conditions applied. (a) MS instrumentation, 
(b) MS resolving power, (c) MS/MS resolving power. Resolving 
power is defined at m/z 200 for orbitrap instruments, while for ICR 
instruments it is defined at m/z 400. Please note that several research 
groups generated datasets with different instruments and settings. 
Data Analysis and Validation Strategies. Strategies for data analysis 
were highly diverse (Figure 5), reflecting the variety in the XL-MS 
field where nearly every group possesses their own software tools 
tailored to fit their specific needs. This enormous variety is current-
ly one of the most critical issues in XL-MS and we consider it as 
important contribution of this study to reflect this diversity. The 
false discovery rate (FDR) plays an important role in this context 
and from this study it arose that most of the groups apply an FDR 
of 5% (Figure 5b). Manual validation of the cross-links was per-
formed for 66% of the experiments, while in 34%, the data sets were 
not manually checked. It is important to note that a mechanism to 
control the FDR should exist in the software, although proper FDR 
control is not trivial for small search spaces, manual validation 
strategies might be especially beneficial in such cases. Some strate-
gies provide additional layers of evidence that can be used to better 
control the error rate. For example, isotope-coded, non-cleavable 
linkers provide two independent measures of precursor and frag-
ment masses, and charge state information for fragments inde-
pendent of MS resolution; MS-cleavable linkers provide three 
layers of information - intact precursors, released fragments corre-
sponding to intact peptide chains, and fragments thereof. In ab-
sence of such strategies, we recommend that preferentially both, 
MS and MS/MS data, should be recorded with high mass accuracy 
to rule out a false assignment of cross-linked products. Clearly, 
some of these effects will only become apparent for samples of 
higher complexity. 
 
  
Figure 5. (a) Software tools used in this study (a complete summary is 
found in Table S2; Supporting Information). Red bars indicate that the 
software is applicable only for non-cleavable cross-linkers; blue bars 
indicate that the software can be used for MS-cleavable cross-linkers. 
(b) False discovery rates. (c) Mass tolerances MS. (d) Mass tolerances 
MS/MS. For the Proteome Discoverer, data analysis was performed 
using the XlinkX software node. 
Identified Cross-links. As we left it to the individual participants 
whether to use in-solution or in-gel digestion as work-up method 
before LC/MS/MS analysis, 47 data sets were generated by in-
solution digestion, while 10 samples originated from in-gel diges-
tion (Figure 1). As already mentioned, BSA has a tendency to form 
dimers, which somewhat complicates data analysis. In case only the 
BSA monomer band is used for in-gel digestion and subsequent 
generation of the cross-linking data set, one can definitely rule out 
that cross-links are in fact representing intermolecular interactions 
between two BSA molecules. On the other hand, during the in-gel 
digestion procedure cross-links might get lost, resulting in an over-
all lower number of cross-linked products. 
Another aspect regards the reaction sites that were considered 
during data analysis. Usually, NHS esters, such as the mainly used 
cross-linkers BS3, DSS, DSBU, and DSSO will react with lysine, but 
they also exhibit a significant reactivity towards serine, threonine 
and tyrosine. The pH used for conducting the cross-linking reac-
tion plays a significant role as amine reactivity is increased at higher 
pH values. Some participants considered only Lys-Lys cross-links 
and neglected the side-reactivity of NHS esters with hydroxy 
group-containing amino acids. In this study, it became apparent 
that Ser, Thr, and Tyr account for ~30% of cross-linking sites 
(Supporting Information, Figure S2). The reactivity of Ser, Thr, 
and Tyr residues obviously depends on the reaction conditions 
(cross-linker, pH value of the solution) as well as local pKa value. It 
is not practicable to consider Lys, Ser, Thr, and Tyr when analyzing 
very complex systems, such as complete proteomes. Therefore we 
suggest as a compromise to consider for whole proteome samples 
only lysine as reactive sites of NHS ester cross-linkers, while for 
single proteins or proteins assemblies, Lys, Ser, Thr, and Tyr might 
be taken into account. 
Figure 6 provides an overview about the reproducibility of results 
obtained with the individual workflows of the participants. For in-
solution digestion workflows, the average number of unique cross-
links in BSA is 78, while for in-gel digestion workflows using only 
the monomeric BSA band, the average number is 44. The term 
“cross-link” refers to the specific amino acid residues that are con-
nected, irrespective of different peptide sequences due to missed 
cleavage sites or modifications. The majority of participating labs 
came up with similar numbers of unique cross-links, independently 
of the cross-linking conditions used (Figure 6a). Three cross-
linking workflows however recorded a significantly higher number 
of cross-links (between 260 and 350). The reason could be a false 
consideration of cross-links from BSA dimers that in some prepara-
tions might have been a dominating species due to inappropriate 
sample treatment. For in-gel digestion workflows, up to 19 over-
length cross-links were reported in one dataset, which could repre-
sent false-positives due to partial unfolding as only the monomeric 
form of BSA was considered in these samples (Figure 6b). 
 
 
Figure 6. Number of BSA cross-links identified. The numbers of cross-
links are plotted for (a) in-solution, (b) in-gel digestion workflows. The 
different cross-linkers are shown as symbols; abbreviations of the cross-
linkers are according to Figure 2. The maximum distances are given for 
each cross-linker, indicating the number of overlength cross-links. 
Every point is a sum of three replicate measurements; replicates of the 
entire experiment are shown in blue, replicates of the LC/MS analyses 
are shown in red; the average number and reproducibility of unique 
cross-links are shown in yellow. 
A more detailed inspection of the unique cross-links revealed high-
ly interesting insights: Datasets created from amine-reactive cross-
linkers (BS3, DSBU, DSS, DSSO, DC4, MC4, CBDPS) using an 
in-solution digestion workflow yielded a total of 1066 unique cross-
links. A complete list of unique cross-links, identified with cross-
linkers reacting with nucleophiles (amine and hydroxy groups) and 
sorted by their reproducibility, is provided as separate file in the 
Supporting Information. 601 of 1066 unique cross links (56%) 
were however identified in only one single dataset (Figure 7). This 
indicates an overall low reproducibility of cross-linking results. The 
curve in Figure 7a shows that the number of unique cross-links 
identified is inversely proportional to the reproducibility of cross-
links in the data sets (coefficient of proportionality ≃ -1). If the 
reproducibility across the data sets is higher than 20%, the effect of 
including more datasets, different reaction conditions, and analyti-
cal parameters determines a linear increment of the number of 
cross-link identifications. The intercept with the y-axis of the result-
ing interpolated linear curves indicates the putative number of 
cross-links in BSA to be between 73 and 88 (Figures 7b). This 
value is very close to the average number of cross-links found (78 
cross-links per dataset for in-solution digestion workflows, Figure 
6a). In Figure 7c, the dependence of the linear correlation on the 
reproducibility of cross-links identified is indicated. This indicates 
that a linear correlation only exists for highly reproducible cross-
links. 
 
  
Figure 7. Comparison of unique cross-links. “Cross-link” denotes the 
unique amino acid residues that are connected by homobifunctional, 
amine-reactive cross-linkers. (a) Number of cross-links in respect to 
their reproducibility among the data sets. (b) Linear extrapolation of all 
(red) or a linear subset (blue) of cross-links resulted in a maximum 
cross-linking number between 73 and 88. (c) The plot summarizes the 
intercepts with the y-axis (red) and the correlation coefficient x 100 
(blue) of the respective linear extrapolations of (a). The linear extrapo-
lation was calculated as shown in (b) by successively removing the data 
points starting from the lowest reproducible value. 
Cross-links identified from in-gel digested BSA monomer band. We 
mapped cross-links in the monomer band of BSA using in-gel diges-
tion (in total 10 datasets) into the published 3D structure of BSA 
(pdb entry 4F5S). For this, homobifunctional, amine-reactive 
linkers were considered as only for this type of cross-linkers a statis-
tical analysis could be performed. Only cross-links identified in at 
least two independent experiments are presented (Figure S3). 30 
out of 230 cross-links exceed the maximum length of 30 Å for the 
cross-linkers employed in this study. These overlength cross-links 
either originate from a false assignment or either by applying non-
suitable experimental conditions. Strikingly, 29 of these overlength 
cross-links were identified in one single experiment only. Cross-
links that were identified in at least two independent experiments 
show one over-length link, while cross-links found in at least three 
independent experiments all fall within the given distance limit of 
30 Å (Figure S4). As guideline for testing cross-linking workflows, 
we provide a list of cross-links that were identified in at least two 
independent experiments from in-gel digestion of the BSA mono-
mer band (Table S3; Supporting Information). 
 
Monomer-dimer equilibrium of BSA. BSA exists in a monomer-dimer 
equilibrium, which may give rise to ambiguities in the identification 
of intra- and inter-molecular cross-link. To address this issue, we 
performed additional experiments with four concentrations of BSA 
(10, 5, 1, and 0.5 µM). Strikingly, the number of overlength cross-
links was very low (only 1 or 2). Moreover, the numbers of over-
length cross-links were similar for all four BSA concentrations used 
(Table S4; Supporting Information). This clearly indicates that a 
BSA concentration of 10 µM, as chosen for this study is suitable for 
conducting cross-linking MS experiments. 
 
Comparison of data acquisition and analysis strategies from one partic-
ipating lab. Because most of the data in this study have been gener-
ated in different laboratories, differences in instrumentation and in 
the software used for data analysis make a direct comparison of 
selected results difficult. However, we used a subset of the data 
generated in a single laboratory to study the effect of the type of 
mass spectrometer and of different search settings on the outcome 
for a relatively simple model system, such as BSA (see Supporting 
Information). 
  
DISCUSSION. 
 
This first community-based cross-linking study reflects the high 
diversity of XL-MS workflows that are currently employed in dif-
ferent labs worldwide. However, it also became apparent that inde-
pendently of the workflow used the results obtained are to some 
degree comparable. For beginners in the field we suggest to use 
BSA as an initial study system and compare the outcome to the 
results obtained herein. As a guideline, the number of cross-links 
expected for BSA should be ~80 for an in-solution workflow, con-
sidering cross-links of the monomer and the dimer. Not unexpect-
edly, our study did not reveal the optimum experimental protocol 
or software to be used in any and all projects. The applications of 
XL-MS are just too diverse so that no single cross-linker, instru-
ment or software tool is expected to be preferable for all scenarios, 
ranging from single protein (as used in this work) to whole-cell 
cross-linking. There are also clear interdependencies between the 
type of cross-linker (cleavable, non-cleavable) and the software that 
can be applied to process such data, as well as between instrument 
type and software as not all fragmentation methods or other MS 
platform-dependent features may be supported. 
As discussed above, XL-MS has become an essential part of many 
structural proteomics studies, but is also a key element in integra-
tive structural biology projects. In such interdisciplinary work, XL 
data may only be a small “puzzle piece” that is combined with other 
experimental data provided by methods such as electron microsco-
py, X-ray crystallography, NMR spectroscopy, small-angle X-ray 
scattering, together with computational modeling. Details about 
how experiments were carried out, how the data were processed, 
and how error rates were assessed are often missing from the publi-
cation, making it difficult for reviewers and readers to assess the 
reliability and credibility of the results. We therefore recommend 
that appropriate consideration should be given to the method 
section of all XL-MS publications by providing all necessary exper-
imental and computational details. Our reporting template could 
serve as a starting point for the “minimum information about a 
cross-linking experiment” that should be included in research 
articles containing XL-MS data. This template is included in the 
Supporting Information for all XL-MS data reports. Sufficient 
information needs to be provided, irrespective of the relative con-
tribution of the cross-linking experiments to a specific project. This 
will also facilitate the cross-referencing of XL-MS data in integra-
tive structural biology projects, for example in the dedicated PDB 
prototype archive, PDB-Dev28. 
Data deposition to a proteomics repository, such as PRIDE, is 
encouraged, as the paucity of available data sets do not assist the 
field in validation, methods evaluation and workflow quality. It 
should be noted that not all data sets assigned to the cross-linking 
category in PRIDE originate from genuine XL-MS experiments (in 
the sense that cross-linking sites were identified), but also contain 
 data from experiments that used cross-linking for the stabilization 
of complexes. The low uptake of data deposition may in part be due 
to the specific nature of XL-MS data. For a “complete” submission 
to ProteomeXchange, allowing a complete integration of search 
results and assignment of a Digital Object Identifier, the reported 
results need to be compliant with a PSI format, such as 
mzIdentML. Although the most recent version of mzIdentML  
(version 1.2) includes support for some XL-MS strategies, such a 
proteomics-centered format cannot easily consider all possible 
workflows, and few dedicated cross-linking search engines offer 
mzIdentML-compliant export at this point. Nevertheless, even a 
“partial” submission will make the raw MS data and results available 
in a user-specified format for download and re-use by interested 
researchers. 
Additional studies that cover a wider range of sample types, such as 
large multi-protein assemblies or even whole proteomes, will be 
required to obtain a better understanding of the benefits and draw-
backs of different experimental workflows. However, we believe 
that this first community-based study serves as the starting point 
for further initiatives in this direction, and encourages the adoption 
of consistent reporting and data sharing guidelines in XL-MS. We 
would like to invite interested parties to participate in the discus-
sion to expand the growing XL-MS community. 
  
CONCLUSION AND GUIDELINES 
 
Although XL-MS is becoming routine for in vitro and in vivo appli-
cations in proteomics and structural biology, this harmonization 
initiative unveiled a great variety in the cross-links identified by 
participating groups, even for the single protein BSA. This under-
lines the need for establishing generally accepted XL-MS protocols 
as well as data analysis and reporting formats. This inter-laboratory 
study on XL-MS represents the first effort of the community to-
wards establishing endorsed and transparent good practice guide-
lines for performing and reporting XL-MS experiments. This study 
also serves as test for all laboratories to evaluate the quality of their 
XL-MS workflows and will aid in improving eventual weaknesses. 
In summary, seven guidelines were deduced from this study as 
framework for conducting XL-MS experiments as detailed in Table 
1. 
 
Table 1. Cross-linking mass spectrometry guidelines. Guidelines 1 
and 2 are derived from the results shown in Figure 5. 
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# Topic Description 
1 FDR 
A mechanism to control the FDR should exist in the software used for cross-link identification. The 
FDR algorithm has to be described in detail. For small search spaces, manual validation strategies might 
be beneficial. 
2 Mass accuracy 
MS and MS/MS data should be recorded and analyzed with high mass accuracy to reduce false assign-
ments of cross-linked products, or multiple lines of evidence from isotope labeling or cleavable linkers 
should be obtained. 
3 Experimental details 
Provide all experimental and computational details. The reporting template (Supporting Information) 
comprises the “minimum information of a cross-linking experiment” that should be included in re-
search articles containing XL-MS data.  
4 Data deposition Deposit raw MS files together with a description of their content and the reporting template to a prote-omics repository, such as PRIDE. 
5 
Visualization of cross-
linked proteins 
Perform SDS-PAGE analysis to evaluate the cross-linking performance under the employed experi-
mental conditions. Check for possible high-molecular weight aggregates. 
6 Cross-linker selectivity 
Consider only lysine and the N-terminus as reactive sites of amine-reactive cross-linkers for whole 
proteome samples. For single proteins or large protein assemblies, consider lysine, N-terminus, serine, 
threonine, and tyrosine as reactive sites. 
7 BSA cross-links 
Approximately 80 cross-links can be expected for cross-linking of BSA using homobifunctional amine-
reactive cross-linkers and an in-solution digestion workflow. 
 This study was conducted within the EU COST Action BM1403.  
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